The global sterile and antiviral packaging market size is estimated to reach USD 25.7 billion in 2024 and is anticipated to reach a value of USD 37.5 billion by 2034. Sales are projected to rise at a CAGR of 3.8% over the forecast period between 2024 and 2034. The revenue generated by sterile and antiviral packaging in 2023 was USD 24.6 billion. The industry is anticipated to exhibit a Y-o-Y growth of 4.6% in 2024.
Sterile and antiviral packaging solutions made up of plastic are used on a large scale in the surgical and medical industry, capturing more than 50% of the total market share. There are medical equipment such as pre-filled syringes, tubes, catheters, lancets, bandages, and gloves packaged in plastic pouches.
The major reason behind using plastic instead of other materials is the ability of plastic to go under sterilization. These critical equipment pass the sterilization process in various stages to ensure that it is free from any type of bacterial, or microbial contamination.
The pharmaceutical and biological industry is set to capture around 50% of the total market share, further expanding at a 4.5% growth rate in the assessment period. The biological industry consists of critical products, which include vaccines, blood and blood components, somatic cells, gene therapy, tissues, and recombinant therapeutic protein.
The preservation of such products during storage and transport is very necessary to sustain their effectiveness. With the motive of sustaining the effectiveness of biological products, safe and antiviral packaging solutions such as pouches having an adhesive seal that offers liquid-tight, secure sample closure are required.
The sterile and antiviral packaging market is set to experience profitable growth during the forecast period. It is projected to create an incremental opportunity of USD 12.9 billion and is predicted to rise 1.5 times the current value through 2034.
Sterile and Antiviral Packaging Industry Forecast
| Attributes | Key Insights |
|---|---|
| Historical Sterile and Antiviral Packaging Industry Size (2023) | USD 24.6 billion |
| Estimated Global Sterile and Antiviral Packaging Market Size (2024E) | USD 25.7 billion |
| Projected Global Sterile and Antiviral Packaging Market Value (2034F) | USD 37.5 billion |
| Value-based CAGR (2024 to 2034) | 3.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Concern towards Spread of Infections during Medical Treatments
The sterile and antiviral packaging market is considered to be the most accelerating market in the pharmaceutical and healthcare industry. The rising prevalence of infectious and non-infectious diseases or viruses such as Corona, Ebola, and others are supplementing the market growth. With time, the types of infections, diseases, and their method of treatment have been changing on a large scale. To stop the spread of infectious diseases, organizations are raising awareness about the steps that need to be taken to prevent infectious diseases.
Increasing demand for protective packaging solutions to prevent the spread of infections by anesthesia equipment, laryngoscope blades, blood pressure cuffs, stethoscopes, and oxygen saturation monitors is propelling the sterile and antiviral packaging market.
According to the study by Amcor Plc, a global packaging company, medical pouches are excellent for packaging medical equipment. Bags and pouches are used prominently for packaging medical apparatus such as canisters, hypodermic needles, thermometers, aspirators, and nebulizers.
Sterilized packaging is an essential component of the medical industry as it can be life-threatening to patients. Increasing pressure from regulatory authorities dealing with the medical and pharmaceutical industry is boosting the sales of sterile and antiviral packaging.
Increasing Demand for Secured Packaging in the Food and Beverage Industry Pushes Sales
A rise in the consumption of packaged foods and beverages across regions is pushing the sale of sterilized and antiviral packaging. The consumption of spoiled, contaminated, and damaged foods and beverages leads to various types of food-borne diseases.
This has generated a necessity for sterile and antiviral packaging solutions with the objective that packaged foods, and beverages reach the customers pure in quality and safe. Packaged food and beverages have to face severe situations after their production phase during storing, warehousing, transport, and distribution.
Sterile and antiviral packaging is the most crucial aspect to keeping the products safe for human consumption and free from contamination due to exposure to excessive sunlight, moisture, and other external factors. Packaging solutions of multiple materials can be made as per the desired product and demand of the end user.
Materials like plastic, glass, metal, paper, and many more offer effective sterile and antiviral packaging solutions for a wide range of food and beverages. Various organizations are stepping ahead to provide sterile and antiviral packaging solutions.
The Environmental Protection Agency (EPA) stated that antimicrobial technology be built into plastic and textiles used in food packaging to prevent the growth of bacteria, mold, mildew, fungi, discoloration and odor. Companies are investing and developing suitable materials that continue with antimicrobial costing is emerging as a trend in the industry.
A study has been going on the development of edible food packaging that can create traction in the packaging industry of food and beverage.
High Production Cost to Hamper the Demand for Sterile and Antiviral Packaging
In the current scenario, there are very few sterile and antiviral packaging manufacturers in the market. These packaging solutions are associated with different types of added costs , such as environmental, safety, and regulatory barriers, which lead to increased costs of the packaging solutions. Thus, high production costs have been a current challenge for the sterile and antiviral packaging industry.
The global market recorded a CAGR of 3.1% during the historical period between 2019 and 2023. Market growth of sterile and antiviral packaging was positive as it reached a value of USD 24.6 billion in 2023 from USD 21.7 billion in 2019.
The industry is experiencing growth due to increased usage of sterile and antiviral packaging options for surgical and medical equipment. Sterile and antiviral packaging has ensured safety for maintaining the sterility and integrity of the product.
Awareness about the effects of the spread of infections has made consumers alert for safe packaging for medical devices. Consequently, consumers have a preferred choice for packaging solutions that ensure zero contamination of medical equipment like syringes, needles, vials, ampoules, and many more. Increasing applications of sterile and antiviral packaging in the healthcare industry have propelled the market.
The use of plastic as a packaging material is projected to rise amid its versatility and ability to be made in any shape and size. It is used as a major sterile and antiviral packaging solution for the pharmaceutical, food, and beverage industries.
On the other hand, metal is also another material used by a variety of end users. Products for sterile and antiviral packaging that require protection from sunlight, moisture, and high temperatures are often packed in sterile and antiviral containers made up of aluminum, tinplate, or stainless steel.
Companies engaged in the manufacturing of pharmaceutical equipment and devices are using plastic as their ideal material for sterile and antiviral packaging options. The rise in demand for packaging solutions with diversity in size and shapes for packaging from several end users is expected to create opportunities in the sterile and antiviral packaging market.
Principal Consultant
The section below covers the future forecast for the sterile and antiviral packaging market in terms of countries. Information on key countries in several parts of the globe, including North America, Latin America, East Asia, South Asia, Europe, Oceania, and MEA, is provided.
Canada is anticipated to remain at the forefront in North America, with a CAGR of 3.5% through 2034. In East Asia, China is projected to witness a CAGR of 4.5% by 2034.
| Country | Value CAGR (2024 to 2034) |
|---|---|
| United States | 3.5% |
| Canada | 3.6% |
| Mexico | 3.8% |
| BENELUX | 4.2% |
| India | 4.8% |
| China | 4.5% |
| New Zealand | 3.3% |
| Northern Africa | 3.8% |
The sterile and antiviral packaging industry in India is projected to create an incremental opportunity of USD 975.6 million over the forecast period. The country is estimated to hold more than 41% share of the South Asia region by 2034. The post-pandemic period has opened eyes regarding the precautions to be taken for the prevention of infections.
Infectious diseases like dengue, hepatitis, and flu can be life-threatening if necessary precautions are not taken. Individuals have become aware of their health safety, which has led to a high demand for sterile and antiviral packaging, as effective packaging can help prevent such infections.
New Zealand’s food and beverage manufacturing sector offers a lot of opportunities for the market. The country is anticipated to hold a value share of 34.8% in 2034 and record a CAGR of 3.3% during the valuation period. The food and beverage manufacturing industry is one of the prominent sectors in New Zealand, accounting for a significant share of total manufacturing income. This is resulting in sales generation in the domestic retail food, grocery, beverage, and products market in New Zealand.
The food and beverages industry in New Zealand registered a Y-o-Y increase of 3.6% in 2024. The packaging is responsible for eliminating spoilage of the product and preserving the product's shelf life. For instance, food and beverage manufacturing companies are using heat-shrink packages for meat products and aluminum cans possessing tamper-evident features for beverages to prevent their deterioration when exposed to heat.
The USA is projected to showcase a CAGR of 3.5% in the forecast period. The growing flexible packaging trend in the country is projected to play a significant role in pushing demand for sterile and antiviral packaging solutions.
The preferences of customers are showing transition with time, and to satisfy their demands, the companies have been forced to offer flexible packaging solutions with variety in size, shapes and capacity. For instance, beverage manufacturers offer carbonated drinks in a wide range of pouches ranging from 100ml, 200ml and 250ml.
By presenting their products with variations in capacities, the companies have been able to cater to customers across all groups as per their food, eating habits, and appetite.
Flexible packaging is likely to be a dominant packaging segment in the country, accounting for a significant share of the total packaging market in the USA The need for safe packaging solutions compelling manufacturers to use sterile and antiviral solutions.
The section contains information about the leading segments in the industry. In terms of packaging type, the vials and ampoules segment is estimated to account for a share of 21.4% by 2034. By end-use, the surgical and medical instruments category is projected to dominate by holding a share of 57.0% by the end of 2034.
| Packaging Type | Vials and Ampoules |
|---|---|
| Value CAGR (2034) | 4.0% |
Vials and ampoules are expected to lead the sterile and antiviral packing market in comparison with other packaging types during the forecast period. These are anticipated to rise at a CAGR of 4.0%, generating an incremental growth opportunity worth USD 2,889.2 million by 2034.
Vials and ampoules are set to be predominantly used for the storage of different types of liquid medical drugs. Ampoules are used for packaging single-dose drugs , whereas vials have multiple doses of drugs and can be reused several times.
They offer excellent barrier properties against sunlight, moisture, and other contaminants, which guarantee in preservation of the drugs and maintain their sterility and quality. Ampoules and vials are made up of glass a highly recyclable material. High demand for eco-friendly and sustainable packaging solutions is also estimated to fuel the growth of sterile and antiviral packaging.
Blisters and clamshells have also proven to be an ideal primary sterile and antiviral packaging solution due to their tight seal ability whereas clamshells are used for secondary packaging purposes.
Companies are looking for blister and clamshells that can be tailored in various shapes and sizes to meet specific packaging requirements. The target segment is anticipated to rise at a CAGR of 3.8% during the forecast period.
| End-use | Surgical and Medical Instruments |
|---|---|
| Value CAGR (2034) | 3.8% |
The surgical and medical instruments segment is estimated to lead the sterile and antiviral packaging industry. It is anticipated to hold around 3.8% CAGR value share in 2034. The rise in the spread of infections at the time of medical treatments and surgeries is contributing to the high demand for sterile and antiviral packaging.
All the devices and apparatus used during any treatment must be free from contamination and properly sterilized. This can be achieved by using effective sterile and antiviral packaging of different materials as per the need and demand.
Smart packaging techniques can be employed , such as radio-frequency identification (RFID), near-field communication (NFC) technology, and indicators to indicate whether the product is sterile or contaminated, which can now be added to pharmaceutical packaging which assists with lots of information , including manufacturing data, expiry date, contents, etc. This might help in avoiding the use of damaged products ultimately reducing the number of infections caused by using contaminated surgical and medical instruments.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The sterile and antiviral packaging market is quite saturated and diverse, which means that large companies are competing with each other as well as with new market entrants. Some leading suppliers of sterile and antiviral packaging include Amcor Plc and Becton, Dickinson, and Company (BD), which provide a wide range of packaging solutions.
These solutions are sterilization films, pouches, containers, and even antiviral coatings on the packaging material. This approach covers all the needs of the pharmaceutical and medical device industries to the extent that they require them.
Other prominent industry players, including BillerudKorsnas AB and Placon Corporation Inc., are also embracing sustainability. BillerudKorsnas focuses on the designing of paper-based packaging materials that are free from contaminants and antiviral coated cartons. At the same time, Placon has a variety of recyclable and bio-based packaging products.
The emphasis on green solutions responds to the development of environmental issues and places these companies well in a market that is gradually shifting its preference to sustainable solutions.
Key Developments in the Sterile and Antiviral Packaging Market:
In terms of packaging types, the industry is divided into thermoform trays, sterile bottles/containers, vials and ampoules, sterile closures, prefilled syringes, blister and clamshells, IV bags and pouches, sterile wraps, and others. The other segments included sterile lids, etc.
A few of the important material types include plastic, glass, metal, paper, and paperboard.
Few of the leading end-use include pharmaceutical and biological, surgical and medical instruments, food and beverage packaging, and others.
Key countries of North America, Latin America, East Asia, South Asia, Europe, Oceania, Middle East and Africa are covered.
The global sterile and antiviral packaging industry is projected to witness a CAGR of 3.8% between 2024 and 2034.
The global sterile and antiviral packaging industry stood at USD 24.6 billion in 2023.
The global sterile and antiviral packaging industry is anticipated to reach USD 37.5 billion by 2034 end.
South Asia is set to record a CAGR of 4.8% in the assessment period.
Dupont De Nemours, Billerud AB and Amcor plc.
1. Executive Summary 2. Industry Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Market Trends and Success Factors 4. Market Background 4.1. Macro-economic and Industry Outlook 4.2. Market Dynamics 4.3. Value Chain Analysis 4.4. List of Key Market Participants (Manufacturers/Channel Partners) 4.5. Analysis of Key Industry Matrices 4.6. Industry Development Roadmap 5. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. Historical Market Volume Analysis 5.2. Future Market Volume Projections 6. Pricing Analysis 7. Global Market Value (US$) Analysis 2019 to 2023 and Forecast 2024 to 2034 7.1. Historical Sales Analysis 7.2. Future Market Size and Growth Projections 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Packaging type 8.1. Thermoform Trays 8.2. Sterile Bottles/Containers 8.3. Vials and Ampoules 8.4. Sterile Closures 8.5. Pre-filled Syringes 8.6. Blister and Clamshells 8.7. IV Bags and Pouches 8.8. Sterile Wraps 8.9. Others 8.9.1. Sterile Lids 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Material type 9.1. Plastic 9.2. Glass 9.3. Metal 9.4. Paper and Paperboard 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End Use 10.1. Pharmaceutical and Biological 10.2. Surgical and Medical 10.3. Food and Beverage Packaging 10.4. Others 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. South Asia 11.5. East Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 14. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 15. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 17. Oceania Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 18. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 19. Sales Analysis 2024 & 2034 by Key Market Segments for Key Countries 20. Competition Outlook including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. Amcor plc 21.2. Billerud AB 21.3. DuPont Inc 21.4. Sonoco Products Company 21.5. Wihuri Group 21.6. ProAmpac LLC 21.7. Berry Global Inc. 21.8. GY Packaging 21.9. Sabre Medical 21.10. Placon Corp 21.11. UFP Technologies, Inc. 21.12. Puracon GmbH 21.13. Oliver Packaging Company 21.14. Westfield Medical Ltd 21.15. Deufol SE 21.16. Technipaq, Inc. 21.17. TekniPlex Ltd 21.18. UFlex Limited 21.19. AptarGroup, Inc. 21.20. Beacon Converters Inc
Packaging
July 2023
REP-GB-1380
306 pages
Explore Packaging Insights
View Reports
Sterile and Antiviral Packaging Market
